FDA staff concerned about safety of Endo's testosterone injection

April 16 (Reuters) - Reviewers for the U.S. Food and Drug Administration said safety data on Endo Health Solutions Inc's testosterone injection Aveed was "concerning," and showed the therapy was associated with severe and immediate post-injection adverse events.